Compounded Topical Finasteride: Check the Formula and the Evidence

Before choosing a compounded hair spray, ask for every active ingredient and the evidence for that exact formulation. FDA says there is no approved topical finasteride product in the United States. A prescription or a familiar ingredient name does not establish that a compounded formula has FDA approval.[1][2]

Read the alert before assuming topical means no systemic effects

FDA's topical-finasteride alert describes 32 adverse-event reports received for 2019–2024. The agency expects absorption through skin into the bloodstream. Reported problems included sexual symptoms, mood changes and insomnia; local irritation and inadvertent transfer to other people are also concerns.[1]

These spontaneous reports cannot establish an individual risk rate: the alert provides no denominator of all users.

FDA warns about transfer to female individuals. Approved finasteride products are contraindicated in pregnancy because of potential abnormalities in a male fetus. Unlike an intact tablet, a topical product has no protective coating. Discuss household exposure before treatment.[1]

What one tested spray showed

A randomized, double-blind trial at 45 European sites studied a particular 0.25% finasteride spray in men aged 18–40 with mild-to-moderate vertex patterned hair loss. It compared topical finasteride, placebo and oral finasteride over 24 weeks. Of 458 randomized participants, 323 completed the study; 250 had evaluable hair-count photographs for its intention-to-treat population.[3]

The adjusted mean target-area hair-count increase at week 24 was 20.2 hairs with the topical treatment and 6.7 with placebo. Maximum plasma finasteride concentrations were lower with the spray than with oral treatment. Lower exposure does not mean no exposure, and a result for this spray does not validate another formula or prove treatment for GLP-1-associated shedding.[3]

Polichem and Almirall funded the study; several authors were current or former Almirall employees. The population, formulation, missing evaluable photographs and 24-week timeframe belong beside the result when discussing its relevance.[3]

Keep compounding and generic approval separate

FDA's compounding questions and answers distinguishes compounded drugs from approved generic medicines. The agency does not verify a compounded drug's safety, effectiveness or quality before marketing. It recognizes patient-specific needs for compounding when an approved medicine is not appropriate, while cautioning against unnecessary use.[2]

Ask who makes the prescription, which pharmacy dispenses it, and why the proposed formula is appropriate for your diagnosis. Keep the prescriber, telehealth service and dispensing pharmacy distinct in your notes. They may be different organizations, and you need a contact for questions after the order arrives.

For a combination formula, record each ingredient and strength. A study of finasteride alone cannot establish the performance of every mixture containing minoxidil or another active. Ask what information supports the combination and what monitoring applies to it.

Take the label to a diagnosis and follow-up discussion

New shedding, a widening part and a changing crown pattern are observations to describe, with dates. Bring photographs and the product label to a qualified clinician rather than assuming any hair-loss medicine fits every pattern. Our hair-shedding history guide can help organize that account.

• Diagnosis: Which type of loss is being treated, and what supports that assessment?
• Formulation: Does the cited research match the ingredients, strength and delivery system proposed?
• Exposure: What handling instructions apply, including contact with other people and pregnancy circumstances?
• Review: Which symptoms require prompt contact, who will answer, and when will progress be assessed?

FDA recommends discussing the risks with the health professional and compounder before starting.[1] If you already use a product and develop concerning symptoms or have an exposure question, contact the prescribing service promptly for advice about the exact product. This article provides no dosing, substitution or application schedule. Our minoxidil evidence article addresses that ingredient separately.

Printed book

How to Keep Your Face on GLP-1

$12.95 + free shipping

Order Now

✓ 30 day money back guarantee

This article provides general education, not a diagnosis or an individual treatment plan. Medication information refers to US sources. Discuss medication, nutrition and cosmetic treatment decisions with qualified clinicians.